Bopindolol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl benzoate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
|
| Routes of administration | Oral |
| Identifiers | |
| CAS Number |
69010-88-4 |
| ATC code | C07AA17 |
| PubChem | CID 44112 |
| DrugBank |
DB08807 |
| ChemSpider |
40146 |
| UNII |
KT304VZO57 |
| KEGG |
D07537 |
| ChEMBL |
CHEMBL357995 |
| Chemical data | |
| Formula | C23H28N2O3 |
| Molar mass | 380.48 g/mol |
| |
| |
| | |
Bopindolol (INN) is a beta blocker. It is an ester which acts as a prodrug for pindolol.[1]
References
- ↑ Nagatomo T, Hosohata Y, Ohnuki T, Nakamura T, Hattori K, Suzuki J, Ishiguro M. (Spring 2001). "Bopindolol: pharmacological basis and clinical implications". Cardiovasc Drug Rev. 19 (1): 9–24. doi:10.1111/j.1527-3466.2001.tb00180.x. PMID 11314603.
| ||||||||||||||||||||||
This article is issued from Wikipedia - version of the Friday, September 04, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
